A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients

PHASE4CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Kidney Transplantation, Cytomegalovirus Infections
Interventions
DRUG

valganciclovir [Valcyte]

Oral, daily for up to 200 days.

Trial Locations (25)

2145

Children'S Hospital At Westmead; Department of Nephrology, Westmead

3052

Royal Children'S Hospital; Department of Nephrology, Parkville

4029

Mater Childrens Hospital, South Brisbane, Herston

20230

Centenario Hospital Miguel Hidalgo, Aguascalientes

20246

Universitätsklinikum für Kinder und Jugendmedizin Hamburg, Hamburg

28046

Hospital Universitario La Paz: Nefrologia Pediatrica, Madrid

30625

KfH Nierenzentrum für Kinder und Jugendliche an der MHH Hannover, Hanover

41013

Hospital Universitario Virgen del Rocio; Servicio de Nefrologia Pediatrica, Seville

41345

Sahlgrenska Sjukhuset; Transplantationskirurgiska Kliniken, Gothenburg

44093

CHU de Nantes - Service de pédiatrie, Nantes

50937

Klinik und Poliklinik für Kinder- und Jugendmedizin- Köln, Uniklinik Köln, Cologne

62428

Instituto Mexicano de Transplantes, Cuernavaca

69120

Klinik Kinderheikunde I des Zentrums für Kinder- und Jugendmedizin, Universität Heidelberg, Heidelberg

75019

Hôpital Robert Debré; Nephrologie pediatrique, Paris

75743

Hop Necker Enfants Malades;Nephrologie Pediatrique, Paris

84108

Uni of Utah Health Science Center; Pediatric Nephrology, Salt Lake City

Unknown

University of Florida Pediatric Nephrology, Gainesville

90095-1752

UCLA Center For Health Sciences; Division of Pediatric Nephrology, Los Angeles

10029-6574

Mount Sinai Medical Center, New York

04038-002

Universidade Federal de Sao Paulo - UNIFESP, São Paulo

06720

Hospital Infantil de Mexico Federico Gomez, México

08035

Hospital Universitari Vall d'Hebron, Barcelona

B4 6NH

Birmingham Children's Hospital, Birmingham

BS2 8BJ

Bristol Royal Hospital For Children, Bristol

G3 8SJ

Royal Hospital For Sick Children; Dept. of Child Health, Glasgow

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01376804 - A Study of Oral Valcyte (Valganciclovir) in Pediatric Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter